Beta-blockers have been a heart care staple for decades, but not all are created equal. New research is clarifying how nebivolol and carvedilol differ in their mechanisms, benefits, and side effects.

Although switching is usually safe and well tolerated, physician judgment concerning individual patient requirements must be maintained. The dose of the first- or second-generation β blocker that the ...

The use of low-dose carvedilol did not significantly improve certain cardiac measures of heart failure risk in long-term survivors of childhood cancer exposed to anthracycline compared with placebo, ...

Cardiac arrhythmias following myocardial infarction (MI) predict poor outcome. β-blockers are effective ventricular antiarrhythmics and angiotensin-converting-enzyme (ACE) inhibitors can prevent both ...

Please provide your email address to receive an email when new articles are posted on . For patients receiving hemodialysis in Taiwan, bisoprolol demonstrated superior safety compared with carvedilol, ...